- White Paper
Now is the time to get your organization ready for the genomic data revolution. From government agencies to the private sector, from healthcare to technology, and everything in between, all organizations need to be prepared for upcoming challenges and opportunities.
The president’s budget calls for a DARPA-like organization for discovering the most innovative and effective treatments for major diseases.
Substance abuse is on the rise in America, but the federal government has an opportunity to leverage data analytics for an effective response.
While the country has struggled with the pandemic, the government has increased support to mental health services, and we must continue to do so to help citizens manage long-term impacts of the virus.
We can apply the lessons from the COVID pandemic to vaccine and treatment submissions moving forward. Here’s how.
COVID-19 showed how just-in-time logistics and ultra-lean supply chains fail in times of uncertainty, compounding health risks and threats to national security. Hedging can help ensure that doesn’t happen again.
The pandemic illustrated telehealth’s importance for our healthcare system but payers must get ahead of fraud and abuse issues to make telehealth effective.
- What We Do
LMI’s compliance approach centers on reducing programmatic risks while minimizing participants’ burden through data analytics and proactive engagement and education.
The SNS must be able to handle novel threats rather than optimizing for emergencies that have already passed. Better analytics, scenario planning, and government collaboration can get us there.